MichaelTomblynMDMS

Breast Cancer, Hematologic Malignancies, Urologic Cancer

Physician

Overview of Dr. Tomblyn

Dr. Michael Tomblyn is a radiation oncologist in Memphis, TN and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital - Memphis and Loyola University Medical Center. He received his medical degree from Rush Medical College of Rush University Medical Center and has been in practice 13 years. Dr. Tomblyn accepts several types of health insurance, listed below. He is one of 90 doctors at Loyola University Medical Center and one of 8 doctors at Baptist Memorial Hospital - Memphis who specialize in Radiation Oncology. He has more than 10 publications and over 250 citings.

Office
6019 Walnut Grove Rd
Memphis, TN 38120
Book by Phone+1(901) 621-5268

Fax+1 901-226-0349

Education & Training

University of MinnesotaResidency, Radiation Oncology, 2005 - 2009
University of MinnesotaInternship, Internal Medicine, 2004 - 2005
Rush Medical College of Rush University Medical CenterClass of 2004

Certifications & Licensure

AR State Medical License 2024 - 2025
MS State Medical License 2024 - 2025
TN State Medical License 2021 - 2025
IL State Medical License 2016 - 2023
FL State Medical License 2009 - 2019
KS State Medical License 2016 - 2018
MN State Medical License 2007 - 2009
American Board of Radiology Radiation Oncology

Clinical Trials

Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL Start of enrollment: 2010 May 01
Withdrawn
Phase 1, Phase 2

Publications & Presentations

PubMed

5 citations
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223.
Mark D. Hurwitz, John R. Buscombe, Heather A. Jacene, Alan K. Klitzke, Dominick Lamonica
American Journal of Clinical Oncology. 2020-08-01
9 citations
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: re...
Michael J. Seider, Stephanie L. Pugh, Corey J. Langer, Gwen Wyatt, W. Demas
Annals of Nuclear Medicine. 2018-08-09
18 citations
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma
Thomas E. Witzig, Michael B Tomblyn, Jamal Misleh, Ebenezer A. Kio, Robert M. Sharkey
Haematologica. 2014-11-01

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment